MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 111 filers reported holding MYOVANT SCIENCES LTD in Q4 2021. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $294 | -99.8% | 10,900 | 0.0% | 0.00% | – |
| Q3 2022 | $196,000 | +45.2% | 10,900 | 0.0% | 0.00% | – |
| Q2 2022 | $135,000 | -6.9% | 10,900 | 0.0% | 0.00% | – |
| Q1 2022 | $145,000 | -14.7% | 10,900 | 0.0% | 0.00% | – |
| Q4 2021 | $170,000 | -94.7% | 10,900 | -98.2% | 0.00% | – |
| Q3 2019 | $3,189,000 | -67.6% | 613,315 | -43.6% | 0.00% | -100.0% |
| Q2 2019 | $9,836,000 | -49.3% | 1,086,893 | +33.8% | 0.00% | -66.7% |
| Q1 2019 | $19,386,000 | +45.7% | 812,148 | +0.2% | 0.00% | +50.0% |
| Q4 2018 | $13,306,000 | -38.1% | 810,848 | +0.2% | 0.00% | -33.3% |
| Q3 2018 | $21,489,000 | +39.3% | 809,380 | +20.0% | 0.00% | +50.0% |
| Q2 2018 | $15,430,000 | +51.6% | 674,703 | +41.0% | 0.00% | 0.0% |
| Q1 2018 | $10,180,000 | +1631.3% | 478,609 | +929.4% | 0.00% | – |
| Q4 2017 | $588,000 | – | 46,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |